NCT02935192 - Phase 3 Trial of Serbian Seasonal Influenza Vaccine | Biotech Hunter

Enrollment

480

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

January 8, 2017

Study Completion Date

March 25, 2017

Conditions

Influenza

Interventions

BIOLOGICAL

Vaccine

Seasonal trivalent split, inactivated influenza vaccine 15 mcg hemagglutinin antigen (HA) of each of A/H1N1; A/H3N2 and B strains; 0.5 mL by IM injection

OTHER

Placebo

Phosphate buffered saline, 0.5 mL by IM injection

Trial Locations (6)

Unknown

Clinical Center of Serbia: Clinic for Infectious and Tropical Diseases, Belgrade

Clinical Center of Serbia: Clinic for Pulmonology, Belgrade

Institute for Students' Healthcare, Belgrade

Institute of Health Care of Workers of the Ministry of Internal Affairs, Belgrade

Jevremova Special gynecology hospital with maternity, Belgrade

General Hospital Vrsac, Vršac